Startseite Insulin-mediated pseudoacromegaly: a report of two pediatric patients
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Insulin-mediated pseudoacromegaly: a report of two pediatric patients

  • Mark Inman EMAIL logo und Munier A. Nour
Veröffentlicht/Copyright: 18. Dezember 2017

Abstract

Background:

Insulin-mediated pseudoacromegaly is a rarely described pediatric phenotype. We present two patients displaying excessive growth associated with marked acanthosis nigricans, hyperinsulinemia and metabolic dysregulation.

Case presentation:

Both patients, of First Nations descent, presented with excessive growth – patient one at 3.92 years (height z-score +3.75) and patient two at 9.0 years (height z-score 5.15). Insulin-like growth factor-1 (IGF-1) levels were normal with appropriate growth hormone suppression, yet marked hyperinsulinemia. Prepubescent growth velocities exceeded 9 cm/year, resulting in final adult height predictions exceeding 3 standard deviations (SDs) of predicted. Clinical courses were complicated by type 2 diabetes, marked acanthosis nigricans and long-standing psychosocial distress.

Conclusions:

Pediatric patients with insulin-mediated pseudoacromegaly are at risk of significant physical, metabolic and psychosocial comorbidities. Unlike adults, the implications in childhood prompt consideration for therapies to decelerate linear growth and avert progression to metabolic dysregulation. Increased recognition of this condition may improve pathophysiological understanding, diagnostic criteria and therapeutic options.


Corresponding author: Mark Inman, MD, FRCPC, Pediatric Endocrinologist, Clinical Assistant Professor, Department of Pediatrics, University of Saskatchewan, 103 Hospital Drive, Saskatoon, SK S7N0W8, Canada, Phone: +306-655-2048/+306-844-1296, Fax: +306-844-1536

Acknowledgments

We acknowledge the significant contributions to this paper from Sharmin Hares. We also would like to acknowledge Raelynn Friesen, pediatric endocrinology nurse with the Division of Pediatric Diabetes and Endocrinology at the University of Saskatchewan, for her involvement with these patients. We also thank the two patients and their respective families for allowing us to share their clinical stories.

  1. Author contributions: MI participated in the background literature review, data collection and review, and manuscript preparation. MN participated in the data review and manuscript preparation. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Flier JS, Moller DE, Moses AC, O’Rahilly S, Chaiken RL, et al. Insulin mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocriol Metab 1993;76:1533–41.Suche in Google Scholar

2. Kausch Ch, Bergemann Ch, Hamann A, Matthaei S. Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts. Exp Clin Endocrinol Diabetes 1999;107:148–54.10.1055/s-0029-1212090Suche in Google Scholar PubMed

3. Kumar S, Durrington PN, O’Rahilly S, Laing I, Humphreys PJ, et al. Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly. J Clin Endocriol Metab 1996;81:3465–9.Suche in Google Scholar

4. Sam AH, Tan T, Meeran K. Insulin-mediated “pseudoacromegaly”. Hormones 2011;10;156–61.10.14310/horm.2002.1306Suche in Google Scholar PubMed

5. Yaqub A, Yaqub N. Insulin-mediated pseudoacromegaly: a case report and review of the literature. W V Med J 2008;104:12–5.Suche in Google Scholar

6. Srinivasan S, Waters MJ, Rowland JE, Baxter RC, Verge CF. Hyperinsulinism and overgrowth without obesity. Arch Dis Child 2003;88:332–4.10.1136/adc.88.4.332Suche in Google Scholar PubMed PubMed Central

7. Littlejohn EE, Weiss RE, Deplewski D, Edidin DV, Rosenfield R. Intractable early childhood obesity as the initial sign of insulin resistant hyperinsulinism and precursor of polycystic ovarian syndrome. J Pediatr Endocrinol Metab 2007;20:41–51.10.1515/JPEM.2007.20.1.41Suche in Google Scholar

8. Slaaby R, Schaffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, et al. Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. J Biol Chem 2006;281:25869–74.10.1074/jbc.M605189200Suche in Google Scholar PubMed

9. Fradkin JE, Eastman RC, Lesniak MA, Roth J. Specificity spillover at the hormone receptor-exploring its role in human disease. N Engl J Med 1989;320:640–5.10.1056/NEJM198903093201005Suche in Google Scholar PubMed

10. Dib K, Whitehead JP, Humphreys PJ, Soos MA, Baynes KC, et al. Impaired activation of Phosphoinositide 3-Kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. J Clin Invest 1998;101:1111–20.10.1172/JCI119884Suche in Google Scholar PubMed PubMed Central

Received: 2017-10-3
Accepted: 2017-11-1
Published Online: 2017-12-18
Published in Print: 2018-1-26

©2018 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. The role of corticosteroid-binding globulin in the evaluation of adrenal insufficiency
  4. Original Articles
  5. Association of sodium intake with insulin resistance in Korean children and adolescents: the Korea National Health and Nutrition Examination Survey 2010
  6. Decrease in serum chemerin through aerobic exercise plus dieting and its association with mitigation of cardio-metabolic risk in obese female adolescents
  7. Ultrasonographic assessment of pubertal breast development in obese children: compliance with the clinic
  8. Associations of leptin, insulin and lipids with retinal microvasculature in children and adolescents
  9. Association of cord blood ghrelin, leptin and insulin concentrations in term newborns with anthropometric parameters at birth
  10. Management of thyrotoxicosis in children and adolescents: 35 years’ experience in 304 patients
  11. Clinical and cytogenetic features of 516 patients with suspected Turner syndrome – a single-center experience
  12. Response to growth hormone treatment in very young patients with growth hormone deficiencies and mini-puberty
  13. Reference centile curves for wrist circumference for Indian children aged 3–18 years
  14. Comparison between two inhibin B ELISA assays in 46,XY testicular disorders of sex development (DSD) with normal testosterone secretion
  15. Genetic mutations associated with neonatal diabetes mellitus in Omani patients
  16. Four novel mutations of the BCKDHA, BCKDHB and DBT genes in Iranian patients with maple syrup urine disease
  17. Improved medical-alert ID ownership and utilization in youth with congenital adrenal hyperplasia following a parent educational intervention
  18. Letter to the Editor
  19. Identification of five mutations in a patient with galactose metabolic disorders
  20. Case Reports
  21. Partial androgen insensitivity syndrome due to somatic mosaicism of the androgen receptor
  22. Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency
  23. Insulin-mediated pseudoacromegaly: a report of two pediatric patients
  24. Novel compound heterozygous variants in the LHCGR gene identified in a subject with Leydig cell hypoplasia type 1
Heruntergeladen am 28.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0398/pdf
Button zum nach oben scrollen